Prosecution Insights
Last updated: April 19, 2026

Sol-Gel Technologies Ltd.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19266342 TREATMENT AND PREVENTION OF BASAL CELL CARCINOMA WITH TOPICAL COMPOSITION COMPRISING PATIDEGIB MCKOY, QUINCY ANDRE 1626 Non-Final OA Jul 11, 2025
18567464 METHODS OF REDUCING ACNE AND ROSACEA RELAPSE RATE AND SEVERITY OLSON, ANDREA STEFFEL 1693 Non-Final OA Dec 06, 2023
18453355 TREATMENT OF SKIN DISORDERS WITH COMPOSITIONS COMPRISING AN EGFR INHIBITOR MACH, ANDRE 1615 Non-Final OA Aug 22, 2023
17521884 METHOD OF TREATING A SKIN DISORDER WITH EGFR INHIBITOR MAHLUM, JONATHAN DAVIS 1625 Final Rejection Nov 09, 2021

Managing Sol-Gel Technologies Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month